Exploring the utility of anti-tNASP antibodies as a cancer screening biomarker in prostate, pancreatic, and ovarian cancer

M. Kasmann, X. Yi, Z. Vaskalis, O. M. Alekseev

Research output: Contribution to conferencePoster

Original languageAmerican English
StatePublished - Aug 13 2022

Disciplines

  • Oncology

Cite this